Yanyang Zhao

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Inflammatory Response

Toll Like Receptor

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoquan Zhu, Chao Chen, Dong Wei, Yong Xu, Siying Liang, Wenlong Jia, Jian Li, Yanchun Qu, Jianpo Zhai, Yaoguang Zhang, Pengjie Wu, Qiang Hao, Linlin Zhang, Wei Zhang, Xinyu Yang, Lin Pan, Ruomei Qi, Yao Li, Feiliang Wang, Rui Yi, Ze Yang, Jianye Wang, Yanyang Zhao
FOXP2 confers oncogenic effects in prostate cancer. eLife 12 (2023)
Yun Xue, Huilian Chen, Shenghao Zhang, Li Bao, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Confers Vascular Protection by Suppressing TLR4/Syk/NLRP3 Signaling in Oxidized Low-Density Lipoprotein-Activated Platelets. Oxidative medicine and cellular longevity 2021 (2021)
Ming Zhang, Yun Xue, Huilian Chen, Lingbing Meng, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs. Oxidative medicine and cellular longevity 2019 (2019)
Kun Chen, Wenjia Sun, Yun Jiang, Beidong Chen, Yanyang Zhao, Jie Sun, Huan Gong, Ruomei Qi
Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs. Oxidative medicine and cellular longevity 2017 (2017)